Preoperative Weight Loss Program for Hepatocellular Carcinoma Patients with High Body Mass Index in Hepatectomy

被引:1
|
作者
Saito, Yu [1 ]
Morine, Yuji [1 ]
Ikemoto, Tetsuya [1 ]
Yamada, Shinichiro [1 ]
Teraoku, Hiroki [1 ]
Yasui-Yamada, Sonoko [2 ]
Nishi, Maki [2 ]
Sakaue, Hiroshi [2 ]
Kamada, Motomu [3 ]
Matsuura, Tetsuya [3 ]
Shimada, Mitsuo [1 ]
机构
[1] Tokushima Univ, Dept Surg, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan
[2] Tokushima Univ Hosp, Dept Nutr, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan
[3] Tokushima Univ Hosp, Dept Rehabil, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan
关键词
PHYSICAL-ACTIVITY; OBESE-PATIENTS; HEPATIC RESECTION; LIVER RESECTION; MULTICENTER; PREVENTION; MECHANISMS; CANCER; SAFETY;
D O I
10.1007/s00268-023-07220-0
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundThis study aimed to investigate the usefulness of a weight-loss program (WLP) in patients with a high body mass index (BMI) prior to liver resection (Hx) for hepatocellular carcinoma (HCC).MethodsAmong 445 patients with HCC who underwent initial Hx between 2000 and 2020, 19 with a high BMI (>= 25.0) were enrolled in our WLP since 2014. For calorie restriction, the amount of energy consumed was calculated as the standard body weight (SBW) kg x 20-25 kcal/day. Protein mass was calculated as SBW kg x 1.0-1.2 g/day to maintain skeletal muscle mass. Patients also performed both aerobic and resistance exercises. The before-and-after changes were compared, and the effect of WLP on the short- and long-term results was investigated.ResultsThe average length of WLP was 21 days, and weight loss was successfully achieved in all patients. Body fat mass was reduced during the program, while skeletal muscle mass was maintained. WLP led to improvements in liver function and fibrotic markers, without tumor progression. There were no postoperative complications (>= Clavien-Dindo [CD] III). A retrospective comparison between with and without WLP using propensity score-matching analysis revealed that WLP group showed better NLR value, however, there were no significant differences in both short and long-term outcomes after Hx based on participation in the WLP.ConclusionsWLP with multidisciplinary intervention improved immune-nutrition status and liver function of obese patients. WLP had not affected both short and long-term outcomes after Hx.
引用
收藏
页码:3348 / 3355
页数:8
相关论文
共 50 条
  • [21] Prognostic value of combined preoperative prognostic nutritional index and body mass index in HCC after hepatectomy
    Ji, Fei
    Liang, Yao
    Fu, Shunjun
    Chen, Dubo
    Cai, XiuQin
    Li, Shaoqiang
    Peng, Baogang
    Liang, Lijian
    Hua, Yunpeng
    HPB, 2017, 19 (08) : 695 - 705
  • [22] Body mass index is a risk factor for postoperative morbidity after laparoscopic hepatectomy of hepatocellular carcinoma: a multicenter retrospective study
    Yang, Shiye
    Ni, Haishun
    Zhang, Aixian
    Zhang, Jixiang
    Liang, Huoqi
    Li, Xing
    Qian, Jiayi
    Zang, Hong
    Ming, Zhibing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (10)
  • [23] Lean body mass index is a marker of advanced tumor features in patients with hepatocellular carcinoma
    deLemos, Andrew Scott
    Zhao, Jing
    Patel, Milin
    Kooken, Banks
    Mathur, Karan
    Nguyen, Hieu Minh
    Mazhar, Areej
    McCarter, Maggie
    Burney, Heather
    Kettler, Carla
    Chalasani, Naga
    Gawrieh, Samer
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (03) : 393 - 404
  • [24] Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma
    Li, Qinggang
    Xing, Hui
    Liu, Dan
    Li, Hui
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
  • [25] Association of Preoperative Prognostic Nutritional Index and Postoperative Acute Kidney Injury in Patients Who Underwent Hepatectomy for Hepatocellular Carcinoma
    Sim, Ji Hoon
    Jun, In-Gu
    Moon, Young-Jin
    Jeon, A. Rom
    Kim, Sung-Hoon
    Kim, Bomi
    Song, Jun-Gol
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (05):
  • [26] Diabetes, Body Mass Index, and Outcomes in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation
    Siegel, Abby B.
    Lim, Emerson A.
    Wang, Shuang
    Brubaker, William
    Rodriguez, Rosa D.
    Goyal, Abhishek
    Jacobson, Judith S.
    Hershman, Dawn L.
    Verna, Elizabeth C.
    Zaretsky, Jonah
    Halazun, Karim
    Dove, Lorna
    Brown, Robert S., Jr.
    Neugut, Alfred I.
    Kato, Tomoaki
    Remotti, Helen
    Coppleson, Yael J.
    Emond, Jean C.
    TRANSPLANTATION, 2012, 94 (05) : 539 - 543
  • [27] Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
    Mathew Vithayathil
    Antonio D’Alessio
    Claudia Angela Maria Fulgenzi
    Naoshi Nishida
    Martin Schönlein
    Johann von Felden
    Kornelius Schulze
    Henning Wege
    Anwaar Saeed
    Brooke Wietharn
    Hannah Hildebrand
    Linda Wu
    Celina Ang
    Thomas U. Marron
    Arndt Weinmann
    Peter R. Galle
    Dominik Bettinger
    Bertram Bengsch
    Arndt Vogel
    Lorenz Balcar
    Bernhard Scheiner
    Pei-Chang Lee
    Yi-Hsiang Huang
    Suneetha Amara
    Mahvish Muzaffar
    Abdul Rafeh Naqash
    Antonella Cammarota
    Valentina Zanuso
    Tiziana Pressiani
    Matthias Pinter
    Alessio Cortellini
    Masatoshi Kudo
    Lorenza Rimassa
    David J. Pinato
    Rohini Sharma
    Hepatology International, 2023, 17 : 904 - 914
  • [28] Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
    Vithayathil, Mathew
    D'Alessio, Antonio
    Weinmann, Arndt
    Galle, Peter
    Fulgenzi, Claudia Angela Maria
    Fessas, Petros
    Bettinger, Dominik
    Bengsch, Bertram
    Vogel, Arndt
    Balcar, Lorenz
    Scheiner, Bernhard
    Muzaffar, Mahvish
    Amara, Suneetha
    Muhammed, Ambreen
    Naqash, Abdul Rafeh
    Personeni, Nicola
    Pressiani, Tiziana
    Cammarota, Antonella
    Pinter, Matthias
    Cortellini, Alessio
    Rimassa, Lorenza
    Pinato, David J.
    Sharma, Rohini
    JOURNAL OF HEPATOLOGY, 2022, 77 : S374 - S375
  • [29] Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma
    Qinggang Li
    Hui Xing
    Dan Liu
    Hui Li
    World Journal of Surgical Oncology, 13
  • [30] Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
    Vithayathil, Mathew
    D'Alessio, Antonio
    Fulgenzi, Claudia Angela Maria
    Nishida, Naoshi
    Schoenlein, Martin
    von Felden, Johann
    Schulze, Kornelius
    Wege, Henning
    Saeed, Anwaar
    Wietharn, Brooke
    Hildebrand, Hannah
    Wu, Linda
    Ang, Celina
    Marron, Thomas U.
    Weinmann, Arndt
    Galle, Peter R.
    Bettinger, Dominik
    Bengsch, Bertram
    Vogel, Arndt
    Balcar, Lorenz
    Scheiner, Bernhard
    Lee, Pei-Chang
    Huang, Yi-Hsiang
    Amara, Suneetha
    Muzaffar, Mahvish
    Naqash, Abdul Rafeh
    Cammarota, Antonella
    Zanuso, Valentina
    Pressiani, Tiziana
    Pinter, Matthias
    Cortellini, Alessio
    Kudo, Masatoshi
    Rimassa, Lorenza
    Pinato, David J.
    Sharma, Rohini
    HEPATOLOGY INTERNATIONAL, 2023, 17 (04) : 904 - 914